Becton, Dickinson and Company (BDX)
NYSE·Healthcare·Medical - Instruments & Supplies
$148.44
-1.17%
Mkt Cap $57.47B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 9, 2026 | $5.15B | $4.49B | -12.84% | $2.21 | $2.91 | +31.67% | — | — |
| Q4 2025 Nov 6, 2025 | $5.91B | $5.89B | -0.27% | $3.92 | $3.96 | +1.02% | — | — |
| Q3 2025 Aug 7, 2025 | $5.49B | $5.51B | +0.41% | $3.40 | $3.68 | +8.24% | — | — |
| Q2 2025 May 1, 2025 | $5.35B | $5.27B | -1.51% | $3.28 | $3.35 | +2.13% | — | — |
| Q1 2025 Feb 5, 2025 | $5.10B | $5.17B | +1.33% | $3.00 | $3.43 | +14.33% | — | — |
| Q4 2024 Nov 7, 2024 | $5.38B | $5.44B | +1.06% | $3.77 | $3.81 | +1.06% | — | — |
| Q3 2024 Aug 1, 2024 | $5.08B | $4.99B | -1.71% | $3.31 | $3.50 | +5.74% | — | — |
| Q2 2024 May 2, 2024 | $5.04B | $5.04B | +0.15% | $2.97 | $3.17 | +6.73% | — | — |
| Q1 2024 Feb 1, 2024 | $4.73B | $4.71B | -0.56% | $2.40 | $2.68 | +11.67% | — | — |
| Q4 2023 Nov 9, 2023 | $5.02B | $5.09B | +1.36% | $3.42 | $3.42 | +0.00% | — | — |
| Q3 2023 Aug 3, 2023 | $5.03B | $4.88B | -3.07% | $2.89 | $2.96 | +2.42% | — | — |
| Q2 2023 May 4, 2023 | $4.68B | $4.82B | +2.92% | $2.75 | $2.86 | +4.00% | — | — |
| Q1 2023 Feb 2, 2023 | $4.53B | $4.59B | +1.26% | $2.67 | $2.98 | +11.61% | — | — |
| Q4 2022 Nov 10, 2022 | $4.71B | $4.76B | +1.09% | $2.73 | $2.75 | +0.73% | — | — |
| Q3 2022 Aug 4, 2022 | $4.47B | $4.64B | +3.84% | $2.49 | $2.66 | +6.83% | — | — |
| Q2 2022 May 5, 2022 | $4.85B | $4.75B | -2.04% | $2.98 | $3.18 | +6.71% | — | — |
| Q1 2022 Feb 3, 2022 | $4.76B | $4.72B | -0.95% | $2.86 | $3.64 | +27.27% | — | — |
| Q4 2021 Nov 4, 2021 | $4.90B | $5.13B | +4.80% | $2.43 | $2.59 | +6.58% | — | — |
| Q3 2021 Aug 5, 2021 | $4.51B | $4.61B | +2.23% | $2.46 | $2.74 | +11.38% | — | — |
| Q2 2021 May 6, 2021 | $4.88B | $4.91B | +0.60% | $3.04 | $3.19 | +4.93% | — | — |